Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Equity (Parenthetical)

v3.25.4
Consolidated Statements of Equity (Parenthetical) - shares
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]      
Beginning balance (in shares) 112,703,460 112,555,352 112,423,893
Conversion of common units to common shares (in shares) 296,046 40,000  
Share-based compensation issuance, net of redemptions (in shares) 211,136 108,108 131,459
Ending balance (in shares) 113,210,642 112,703,460 112,555,352